Insider Transactions in Q4 2024 at Imara Inc. (IMRA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,250
-90.48%
|
$131,250
$25.08 P/Share
|
|
Nov 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,250
+50.0%
|
$10,500
$2.48 P/Share
|
|
Oct 28
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,250
-94.8%
|
$175,000
$28.8 P/Share
|
|
Oct 28
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$12,500
$2.48 P/Share
|
|
Oct 18
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
814
-100.0%
|
$24,420
$30.0 P/Share
|
|
Oct 18
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
814
+50.0%
|
$1,628
$2.48 P/Share
|
|
Oct 18
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
924
-0.09%
|
$27,720
$30.0 P/Share
|
|
Oct 18
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
847
-0.08%
|
$25,410
$30.0 P/Share
|
|
Oct 18
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Indirect |
716
-0.21%
|
$21,480
$30.0 P/Share
|
|
Oct 18
2024
|
Helen Louise Collins CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
816
-100.0%
|
$24,480
$30.0 P/Share
|
|
Oct 18
2024
|
Helen Louise Collins CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
816
+50.0%
|
$1,632
$2.48 P/Share
|
|
Oct 18
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
753
-2.7%
|
$22,590
$30.0 P/Share
|
|
Oct 18
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
817
-0.66%
|
$24,510
$30.0 P/Share
|
|
Oct 15
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,270
-1.01%
|
$34,290
$27.67 P/Share
|
|
Oct 09
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
37,878
-1.8%
|
$1,060,584
$28.32 P/Share
|
|
Oct 09
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
16,710
-0.82%
|
$467,880
$28.3 P/Share
|
|
Oct 08
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
13,267
-0.62%
|
$371,476
$28.24 P/Share
|
|
Oct 08
2024
|
Rahul D. Ballal |
SELL
Open market or private sale
|
Direct |
10,420
-31.81%
|
$291,760
$28.17 P/Share
|
|
Oct 08
2024
|
Rahul D. Ballal |
BUY
Exercise of conversion of derivative security
|
Direct |
10,420
+14.6%
|
$125,040
$12.6 P/Share
|
|
Oct 08
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
13,267
-0.64%
|
$371,476
$28.23 P/Share
|
|
Oct 07
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,270
-100.0%
|
$34,290
$27.51 P/Share
|
|
Oct 07
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,270
+38.84%
|
$2,540
$2.48 P/Share
|
|
Oct 07
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,730
-0.26%
|
$73,710
$27.5 P/Share
|
|
Oct 07
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
2,707
-0.25%
|
$73,089
$27.61 P/Share
|
|
Oct 04
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
2,825
-2.2%
|
$76,275
$27.51 P/Share
|
|
Oct 04
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,218
-100.0%
|
$275,886
$27.51 P/Share
|
|
Oct 04
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,218
+50.0%
|
$20,436
$2.48 P/Share
|
|
Oct 04
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
12,206
-1.16%
|
$329,562
$27.51 P/Share
|
|
Oct 04
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
7,522
-0.7%
|
$203,094
$27.51 P/Share
|
|
Oct 01
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
521
-100.0%
|
$14,067
$27.54 P/Share
|
|
Oct 01
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+50.0%
|
$1,042
$2.48 P/Share
|
|
Oct 01
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
526
-0.05%
|
$14,202
$27.54 P/Share
|
|
Oct 01
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
527
-0.05%
|
$14,229
$27.54 P/Share
|
|
Oct 01
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
518
-0.4%
|
$13,986
$27.54 P/Share
|